Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 16,385,000 | 17,621,000 | 21,244,000 | 19,484,000 | 18,808,000 |
| Cost of Goods | 4,619,000 | 4,610,000 | 5,598,000 | 5,277,000 | 5,140,000 |
| Gross Profit | 11,766,000 | 13,011,000 | 15,646,000 | 14,207,000 | 13,668,000 |
| Operating Expenses | 8,875,000 | 8,841,000 | 8,665,000 | 8,136,000 | 8,348,000 |
| Operating Income | 2,891,000 | 4,170,000 | 6,981,000 | 6,071,000 | 5,320,000 |
| Other Income | 0 | -1,830,000 | 0 | 0 | 282,000 |
| Pre-tax Income | 2,891,000 | 2,340,000 | 6,981,000 | 6,071,000 | 5,602,000 |
| Income Tax | 311,000 | -161,000 | 1,721,000 | 1,558,000 | 1,182,000 |
| Net Income Continuous | 2,580,000 | 2,501,000 | 5,260,000 | 4,513,000 | 4,420,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 7,442,000 |
| Minority Interests | 17,000 | 541,000 | 1,551,000 | 1,411,000 | 1,250,000 |
| Net Income | $2,563,000 | $1,960,000 | $3,709,000 | $3,102,000 | $10,612,000 |
| EPS Basic Total Ops | 1.56 | 1.17 | 2.18 | 1.80 | 5.35 |
| EPS Basic Continuous Ops | 1.57 | 1.50 | 3.09 | 2.63 | 1.63 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 3.72 |
| EPS Diluted Total Ops | 1.54 | 1.16 | 2.16 | 1.79 | 5.34 |
| EPS Diluted Continuous Ops | 1.55 | 1.48 | 3.06 | 2.61 | 1.63 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 3.71 |
| EBITDA(a) | $3,654,000 | $5,143,000 | $7,609,000 | $6,678,000 | $6,027,000 |